|
DE144266C
(enExample)
|
|
|
|
|
|
US3138588A
(en)
|
1962-08-24 |
1964-06-23 |
American Home Prod |
17-ketals of estrone and derivatives thereof
|
|
US3177206A
(en)
|
1963-03-07 |
1965-04-06 |
American Home Prod |
Selective bromination of a-ring aromatic 17-ketalized steroids
|
|
US3433785A
(en)
|
1966-07-11 |
1969-03-18 |
Sterling Drug Inc |
15,16-disubstituted aromatic steroids,intermediates and processes
|
|
US3673180A
(en)
|
1970-06-18 |
1972-06-27 |
Merck & Co Inc |
19-nor-6,6-ethylene-20-spiroxenes
|
|
US4792620A
(en)
|
1983-10-14 |
1988-12-20 |
Bp Chemicals Limited |
Carbonylation catalysts
|
|
US4739078A
(en)
|
1984-02-17 |
1988-04-19 |
The Upjohn Company |
Use of borohydride-salt lanthanide salt reagents for stereo selective reduction of C-15-keto prostaglandin precursors
|
|
IE60780B1
(en)
|
1987-01-23 |
1994-08-10 |
Akzo Nv |
New 11-aryl steroid derivatives
|
|
DE3710728A1
(de)
|
1987-03-31 |
1988-10-13 |
Schering Ag |
Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
|
|
US5073374A
(en)
|
1988-11-30 |
1991-12-17 |
Schering Corporation |
Fast dissolving buccal tablet
|
|
US5340586A
(en)
|
1991-04-12 |
1994-08-23 |
University Of Southern California |
Methods and formulations for use in treating oophorectomized women
|
|
JPH07101977A
(ja)
|
1993-10-05 |
1995-04-18 |
Kureha Chem Ind Co Ltd |
ホルモン作用を軽減した新規なエストラジオール誘導体及びその増殖因子阻害剤
|
|
WO1997004752A1
(en)
|
1995-07-26 |
1997-02-13 |
Duramed Pharmaceuticals, Inc. |
Pharmaceutical compositions of conjugated estrogens and methods for their use
|
|
US6117446A
(en)
|
1999-01-26 |
2000-09-12 |
Place; Virgil A. |
Drug dosage unit for buccal administration of steroidal active agents
|
|
TW548277B
(en)
|
1999-07-16 |
2003-08-21 |
Akzo Nobel Nv |
Orally active androgens
|
|
US20020132801A1
(en)
|
2001-01-11 |
2002-09-19 |
Schering Aktiengesellschaft |
Drospirenone for hormone replacement therapy
|
|
EP1260225A1
(en)
|
2001-05-18 |
2002-11-27 |
Pantarhei Bioscience B.V. |
A pharmaceutical composition for use in hormone replacement therapy
|
|
US8048869B2
(en)
|
2001-05-18 |
2011-11-01 |
Pantarhei Bioscience B.V. |
Pharmaceutical composition for use in hormone replacement therapy
|
|
DK1390042T3
(da)
|
2001-05-23 |
2008-03-31 |
Pantarhei Bioscience Bv |
System for administration af et lægemiddel omfattende tetrahydroxyleret östrogen til anvendelse i hormonal svangerskabsforebyggelse
|
|
ES2337129T3
(es)
|
2001-05-23 |
2010-04-21 |
Pantarhei Bioscience B.V. |
Sistema de administracion de medicamento comprendiendo un estrogeno tetrahidroxilado para el uso en la anticoncepcion hormonal.
|
|
WO2003018026A1
(en)
|
2001-08-31 |
2003-03-06 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
WO2003041718A1
(en)
|
2001-11-15 |
2003-05-22 |
Pantarhei Bioscience B.V. |
Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
|
|
US6723348B2
(en)
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
|
HU227198B1
(en)
|
2001-11-27 |
2010-10-28 |
Richter Gedeon Nyrt |
Pharmaceutical composition for emergency contraception containing levonorgestrel
|
|
DK1478373T3
(da)
|
2002-02-21 |
2007-01-15 |
Schering Ag |
Farmaceutisk præparat omfattende ét eller flere steroider, én eller flere tetrahydrofolatbestanddele og vitamin B 12
|
|
US20050147670A1
(en)
|
2002-05-29 |
2005-07-07 |
Impax Laboratories Inc. |
Oral disintegrating dosage forms
|
|
CN100352445C
(zh)
|
2002-06-11 |
2007-12-05 |
潘塔希生物科学股份有限公司 |
一种皮肤护理组合物及其用途
|
|
CN1691947B
(zh)
|
2002-06-11 |
2011-11-23 |
潘塔希生物科学股份有限公司 |
雌激素成分在制备用于治疗或预防免疫介导的疾病中的应用以及包含所述雌激素成分的药物组合物
|
|
ES2299730T3
(es)
|
2002-07-12 |
2008-06-01 |
Pantarhei Bioscience B.V. |
Composicion farmaceutica que comprende derivados de estetrol para el uso en la terapia del cancer.
|
|
CA2503549C
(en)
|
2002-10-23 |
2012-07-10 |
Pantarhei Bioscience B.V. |
Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
|
|
ATE469165T1
(de)
|
2002-11-08 |
2010-06-15 |
Pantarhei Bioscience Bv |
Synthese von oestetrol aus von oestron abgeleiteten steroiden
|
|
ES2274456T3
(es)
|
2003-05-22 |
2007-05-16 |
Pantarhei Bioscience B.V. |
Uso de composiciones que comprenden un componente estrogenico para el tratamiento y la prevencion del dolor musculoesqueletico.
|
|
ZA200709854B
(en)
|
2005-05-26 |
2009-03-25 |
Solvay Pharm Gmbh |
17ß-HSD1 and STS inhibitors
|
|
DE112006002611A5
(de)
|
2005-07-25 |
2008-07-03 |
Technische Universität Dresden |
Rna-abhängige rna-polymerase, verfahren und kits zur amplifikation und / oder markierung von rna
|
|
US20070048369A1
(en)
|
2005-08-26 |
2007-03-01 |
National Starch And Chemical Investment Holding Corporation |
Mucosal delivery tablet
|
|
CA2636638C
(en)
|
2006-01-09 |
2014-02-18 |
Pantarhei Bioscience B.V. |
A method of treating an acute vascular disorder
|
|
US20080113953A1
(en)
|
2006-06-08 |
2008-05-15 |
Warner Chilcott Company, Inc. |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
EP2029146B8
(en)
|
2006-06-08 |
2018-02-21 |
Allergan Pharmaceuticals International Limited |
Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty
|
|
US20070286819A1
(en)
|
2006-06-08 |
2007-12-13 |
Warner Chilcott Company, Inc. |
Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
|
|
GB0621926D0
(en)
|
2006-11-03 |
2006-12-13 |
Medlock Medical Ltd |
Multi directional stretch tubular bandages
|
|
CL2007003429A1
(es)
|
2006-11-29 |
2008-04-11 |
Wyeth Corp |
Tableta bi-capa que comprende una primera capa con al menos un estrogeno y una segunda capa con uno o mas agentes terapeuticos seleccionados entre un modulador selectivo del receptor de estrogeno y un agente progestacional; proceso de produccion, uti
|
|
WO2008079245A2
(en)
|
2006-12-20 |
2008-07-03 |
Duramed Pharmaceuticals, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
ATE473746T1
(de)
|
2007-01-08 |
2010-07-15 |
Pantarhei Bioscience Bv |
Verfahren zur behandlung oder prävention von unfruchtbarkeit bei weiblichen säugern und pharmazeutisches kit zur anwendung dieses verfahrens
|
|
CL2008000095A1
(es)
|
2007-01-12 |
2008-05-16 |
Wyeth Corp |
Composicion de tableta en tableta que comprende una tableta central con estrogenos, un rellenador/diluyente, un rellenador/aglomerante, un componente polimerico y una capa de tableta exterior comprimida con agentes terapeuticos, un rellenador/diluyen
|
|
ATE537833T1
(de)
|
2007-06-21 |
2012-01-15 |
Pantarhei Bioscience Bv |
Behandlung des mekoniumaspirationssyndroms mit östrogenen
|
|
EP2170346B1
(en)
|
2007-07-19 |
2011-11-16 |
Pantarhei Bioscience B.V. |
Treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation
|
|
JPWO2009028676A1
(ja)
|
2007-08-31 |
2010-12-02 |
国立大学法人名古屋大学 |
カルボニル化合物の製造方法およびカルボニル化合物の製造に用いる酸化促進剤
|
|
EP2077272A1
(en)
|
2007-12-21 |
2009-07-08 |
Affibody AB |
Polypeptide libraries with a predetermined scaffold
|
|
EP2077273B1
(en)
|
2007-12-31 |
2011-09-14 |
Animal Technology Institute Taiwan |
Methods for separating casein from soluble proteins in a composition
|
|
US20110250274A1
(en)
|
2008-09-19 |
2011-10-13 |
Shaked Ze Ev |
Estriol formulations
|
|
DE102009007771B4
(de)
|
2009-02-05 |
2012-02-16 |
Bayer Schering Pharma Aktiengesellschaft |
Bukkales Applikationssystem, 17α-Estradiol enthaltend
|
|
CN102058604A
(zh)
|
2009-11-17 |
2011-05-18 |
北京万全阳光医学技术有限公司 |
一种含有地诺孕素和戊酸雌二醇的药物组合物及其制备方法
|
|
US9603860B2
(en)
|
2010-07-28 |
2017-03-28 |
Laboratorios Leon Farma Sa |
Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
|
|
CA2835979C
(en)
|
2011-06-01 |
2018-05-01 |
Estetra S.A. |
Process for the production of estetrol intermediates
|
|
US11053274B2
(en)
|
2011-06-01 |
2021-07-06 |
Estetra S.P.R.L. |
Process for the production of estetrol intermediates
|
|
EP2383279A1
(en)
*
|
2011-07-19 |
2011-11-02 |
Pantarhei Bioscience B.V. |
Process for the preparation of estetrol
|
|
US10179107B2
(en)
|
2011-07-19 |
2019-01-15 |
Pantarhei Bioscience B.V. |
Tablet containing dehydroepiandrosterone (DHEA)
|
|
LT2741824T
(lt)
|
2011-08-11 |
2017-06-26 |
Estetra S.P.R.L. |
Estetrolio panaudojimas kaip skubaus kontraceptiko
|
|
WO2013037708A1
(en)
|
2011-09-16 |
2013-03-21 |
Ferring B.V. |
A fast dissolving pharmaceutical composition
|
|
EP2764008B1
(en)
|
2011-10-07 |
2016-08-17 |
Estetra S.P.R.L. |
Process for the production of estetrol
|
|
EP2653163A1
(en)
|
2012-04-19 |
2013-10-23 |
Université de Liège |
Estrogenic components for use in the treatment of neurological disorders
|
|
US9808470B2
(en)
|
2012-04-19 |
2017-11-07 |
Universite De Liege |
Estrogenic components for use in the treatment of neurological disorders
|
|
WO2014159377A1
(en)
|
2013-03-14 |
2014-10-02 |
Teva Women's Health, Inc. |
Compositions containing tanaproget and natural estrogens
|
|
CA2924255C
(en)
|
2013-09-18 |
2022-11-22 |
Crystal Pharma, S.A.U. |
Process for the preparation of estetrol
|
|
NZ720906A
(en)
|
2013-12-12 |
2022-04-29 |
Estetra Sprl |
Orally disintegrating solid dosage unit containing an estetrol component
|
|
JP6813150B2
(ja)
|
2015-06-18 |
2021-01-13 |
エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ |
エステトロールを含有する口腔内崩壊錠
|
|
US11147771B2
(en)
|
2015-06-18 |
2021-10-19 |
Estetra Sprl |
Orodispersible dosage unit containing an estetrol component
|
|
ES2877186T3
(es)
|
2015-06-18 |
2021-11-16 |
Estetra Sprl |
Comprimido orodispersable que contiene estetrol
|
|
CN116077454A
(zh)
|
2015-06-18 |
2023-05-09 |
埃斯特拉有限责任公司 |
含雌四醇组分的口腔分散剂量单位
|